290 related articles for article (PubMed ID: 29348298)
1. A Review of Prostate Cancer Genome-Wide Association Studies (GWAS).
Benafif S; Kote-Jarai Z; Eeles RA;
Cancer Epidemiol Biomarkers Prev; 2018 Aug; 27(8):845-857. PubMed ID: 29348298
[TBL] [Abstract][Full Text] [Related]
2. A systematic review of replication studies of prostate cancer susceptibility genetic variants in high-risk men originally identified from genome-wide association studies.
Ishak MB; Giri VN
Cancer Epidemiol Biomarkers Prev; 2011 Aug; 20(8):1599-610. PubMed ID: 21715604
[TBL] [Abstract][Full Text] [Related]
3. Germline genetic variants associated with prostate cancer and potential relevance to clinical practice.
Goh CL; Eeles RA
Recent Results Cancer Res; 2014; 202():9-26. PubMed ID: 24531773
[TBL] [Abstract][Full Text] [Related]
4. Association between Prostinogen (KLK15) genetic variants and prostate cancer risk and aggressiveness in Australia and a meta-analysis of GWAS data.
Batra J; Lose F; O'Mara T; Marquart L; Stephens C; Alexander K; Srinivasan S; Eeles RA; Easton DF; Al Olama AA; Kote-Jarai Z; Guy M; Muir K; Lophatananon A; Rahman AA; Neal DE; Hamdy FC; Donovan JL; Chambers S; Gardiner RA; Aitken J; Yaxley J; Kedda MA; Clements JA; Spurdle AB
PLoS One; 2011; 6(11):e26527. PubMed ID: 22132073
[TBL] [Abstract][Full Text] [Related]
5. Pathway Analysis of Genes Identified through Post-GWAS to Underpin Prostate Cancer Aetiology.
Farashi S; Kryza T; Batra J
Genes (Basel); 2020 May; 11(5):. PubMed ID: 32397189
[TBL] [Abstract][Full Text] [Related]
6. Genetic analysis of the principal genes related to prostate cancer: a review.
Alvarez-Cubero MJ; Saiz M; Martinez-Gonzalez LJ; Alvarez JC; Lorente JA; Cozar JM
Urol Oncol; 2013 Nov; 31(8):1419-29. PubMed ID: 23141781
[TBL] [Abstract][Full Text] [Related]
7. Profile of common prostate cancer risk variants in an unscreened Romanian population.
Iordache PD; Mates D; Gunnarsson B; Eggertsson HP; Sulem P; Guðmundsson J; Benónísdóttir S; Csiki IE; Rascu S; Radavoi D; Ursu R; Staicu C; Calota V; Voinoiu A; Jinga M; Rosoga G; Danau R; Sima SC; Badescu D; Suciu N; Radoi V; Manolescu A; Rafnar T; Halldórsson BV; Jinga V; Stefánsson K
J Cell Mol Med; 2018 Mar; 22(3):1574-1582. PubMed ID: 29266682
[TBL] [Abstract][Full Text] [Related]
8. Post-GWAS in prostate cancer: from genetic association to biological contribution.
Farashi S; Kryza T; Clements J; Batra J
Nat Rev Cancer; 2019 Jan; 19(1):46-59. PubMed ID: 30538273
[TBL] [Abstract][Full Text] [Related]
9. Evaluating genetic risk for prostate cancer among Japanese and Latinos.
Cheng I; Chen GK; Nakagawa H; He J; Wan P; Laurie CC; Shen J; Sheng X; Pooler LC; Crenshaw AT; Mirel DB; Takahashi A; Kubo M; Nakamura Y; Al Olama AA; Benlloch S; Donovan JL; Guy M; Hamdy FC; Kote-Jarai Z; Neal DE; Wilkens LR; Monroe KR; Stram DO; Muir K; Eeles RA; Easton DF; Kolonel LN; Henderson BE; Le Marchand L; Haiman CA
Cancer Epidemiol Biomarkers Prev; 2012 Nov; 21(11):2048-58. PubMed ID: 22923026
[TBL] [Abstract][Full Text] [Related]
10. Prostate cancer predisposition loci and risk of metastatic disease and prostate cancer recurrence.
Ahn J; Kibel AS; Park JY; Rebbeck TR; Rennert H; Stanford JL; Ostrander EA; Chanock S; Wang MH; Mittal RD; Isaacs WB; Platz EA; Hayes RB
Clin Cancer Res; 2011 Mar; 17(5):1075-81. PubMed ID: 21343373
[TBL] [Abstract][Full Text] [Related]
11. The genetic epidemiology of prostate cancer and its clinical implications.
Eeles R; Goh C; Castro E; Bancroft E; Guy M; Al Olama AA; Easton D; Kote-Jarai Z
Nat Rev Urol; 2014 Jan; 11(1):18-31. PubMed ID: 24296704
[TBL] [Abstract][Full Text] [Related]
12. A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease.
Amin Al Olama A; Kote-Jarai Z; Schumacher FR; Wiklund F; Berndt SI; Benlloch S; Giles GG; Severi G; Neal DE; Hamdy FC; Donovan JL; Hunter DJ; Henderson BE; Thun MJ; Gaziano M; Giovannucci EL; Siddiq A; Travis RC; Cox DG; Canzian F; Riboli E; Key TJ; Andriole G; Albanes D; Hayes RB; Schleutker J; Auvinen A; Tammela TL; Weischer M; Stanford JL; Ostrander EA; Cybulski C; Lubinski J; Thibodeau SN; Schaid DJ; Sorensen KD; Batra J; Clements JA; Chambers S; Aitken J; Gardiner RA; Maier C; Vogel W; Dörk T; Brenner H; Habuchi T; Ingles S; John EM; Dickinson JL; Cannon-Albright L; Teixeira MR; Kaneva R; Zhang HW; Lu YJ; Park JY; Cooney KA; Muir KR; Leongamornlert DA; Saunders E; Tymrakiewicz M; Mahmud N; Guy M; Govindasami K; O'Brien LT; Wilkinson RA; Hall AL; Sawyer EJ; Dadaev T; Morrison J; Dearnaley DP; Horwich A; Huddart RA; Khoo VS; Parker CC; Van As N; Woodhouse CJ; Thompson A; Dudderidge T; Ogden C; Cooper CS; Lophatonanon A; Southey MC; Hopper JL; English D; Virtamo J; Le Marchand L; Campa D; Kaaks R; Lindstrom S; Diver WR; Gapstur S; Yeager M; Cox A; Stern MC; Corral R; Aly M; Isaacs W; Adolfsson J; Xu J; Zheng SL; Wahlfors T; Taari K; Kujala P; Klarskov P; Nordestgaard BG; Røder MA; Frikke-Schmidt R; Bojesen SE; FitzGerald LM; Kolb S; Kwon EM; Karyadi DM; Orntoft TF; Borre M; Rinckleb A; Luedeke M; Herkommer K; Meyer A; Serth J; Marthick JR; Patterson B; Wokolorczyk D; Spurdle A; Lose F; McDonnell SK; Joshi AD; Shahabi A; Pinto P; Santos J; Ray A; Sellers TA; Lin HY; Stephenson RA; Teerlink C; Muller H; Rothenbacher D; Tsuchiya N; Narita S; Cao GW; Slavov C; Mitev V; ; ; ; ; Chanock S; Gronberg H; Haiman CA; Kraft P; Easton DF; Eeles RA
Hum Mol Genet; 2013 Jan; 22(2):408-15. PubMed ID: 23065704
[TBL] [Abstract][Full Text] [Related]
13. Genetic predisposition to prostate cancer.
Benafif S; Eeles R
Br Med Bull; 2016 Dec; 120(1):75-89. PubMed ID: 27941040
[TBL] [Abstract][Full Text] [Related]
14. Validation of prostate cancer risk variants rs10993994 and rs7098889 by CRISPR/Cas9 mediated genome editing.
Wang X; Hayes JE; Xu X; Gao X; Mehta D; Lilja HG; Klein RJ
Gene; 2021 Feb; 768():145265. PubMed ID: 33122083
[TBL] [Abstract][Full Text] [Related]
15. Genetic predisposition to prostate cancer: an update.
Ni Raghallaigh H; Eeles R
Fam Cancer; 2022 Jan; 21(1):101-114. PubMed ID: 33486571
[TBL] [Abstract][Full Text] [Related]
16. Genome-wide association studies on prostate cancer: the end or the beginning?
Chen R; Ren S; Sun Y
Protein Cell; 2013 Sep; 4(9):677-86. PubMed ID: 23982739
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide two-locus interaction analysis identifies multiple epistatic SNP pairs that confer risk of prostate cancer: A cross-population study.
Shen J; Li Z; Song Z; Chen J; Shi Y
Int J Cancer; 2017 May; 140(9):2075-2084. PubMed ID: 28124475
[TBL] [Abstract][Full Text] [Related]
18. Genome-wide association study of prostate cancer mortality.
Penney KL; Pyne S; Schumacher FR; Sinnott JA; Mucci LA; Kraft PL; Ma J; Oh WK; Kurth T; Kantoff PW; Giovannucci EL; Stampfer MJ; Hunter DJ; Freedman ML
Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2869-76. PubMed ID: 20978177
[TBL] [Abstract][Full Text] [Related]
19. Downstream targets of GWAS-detected genes for breast, lung, and prostate and colon cancer converge to G1/S transition pathway.
Gorlova OY; Demidenko EI; Amos CI; Gorlov IP
Hum Mol Genet; 2017 Apr; 26(8):1465-1471. PubMed ID: 28334950
[TBL] [Abstract][Full Text] [Related]
20. Genetic variants associated with predisposition to prostate cancer and potential clinical implications.
Goh CL; Schumacher FR; Easton D; Muir K; Henderson B; Kote-Jarai Z; Eeles RA
J Intern Med; 2012 Apr; 271(4):353-65. PubMed ID: 22308973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
